Document is current
Any future updates will be listed below
-
Authors
Parker, Karen J.
Buckmaster, Christine L.
Hyde, Shellie A.
Schatzberg, Alan F.
Lyons, David M.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH66537, MH77884, MH47573)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DA16902)
Stanford University
- License Information
-
More Information
Article History
Received: 30 August 2019
Accepted: 22 October 2019
First Online: 7 November 2019
Competing interests
: Dr. Schatzberg reports receiving lecture fees from, and owning shares in, Pfizer, Inc. Dr. Parker, Ms. Buckmaster, Ms. Hyde and Dr. Lyons report no biomedical interests or potential conflicts of interest with regard to this report.
